Eisen

Quick links to important sections

Eisen

Method of action: Antianemic

Treatment option: Iron Deficiency

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Eisen

Property Description
Active ingredient Iron Dextran
Form Solution for injection (Parenteral)
Pharmacological class Antianemic Agent
Primary purpose Replenishment of iron stores
Origin Synthetic macromolecular complex

Eisen is a specialized, prescription-only medicine that is classified as an iron replacement product. This medication belongs to the antianemic agent pharmacological class and is developed to manage a documented state of iron deficiency. The primary active substance, Iron Dextran, is a compound that is clinically recognized for its efficacy in patients unable to tolerate or adequately absorb iron from oral treatments. This preparation is typically utilized when a rapid and substantial increase in iron levels is required.


Composition and Form: Injectable Parenteral Preparation

The medicine is defined by its active ingredient, Iron Dextran, which is a synthetic, macromolecular complex. This chemical structure consists of ferric hydroxide (elemental iron) tightly bound to a carrier molecule, dextran, forming a stable colloidal solution. As a parenteral preparation, Eisen is supplied as a solution for injection, which is administered either intravenously or intramuscularly. This delivery method is a key differentiating factor from oral treatments; it ensures the iron bypasses the gastrointestinal tract and is made directly available to the body’s systems.


Why is an Injectable Iron Complex Used?

The fundamental purpose of using this parenteral approach is to ensure highly efficient iron replacement and to quickly replenish the body's depleted iron stores. This route guarantees that the micronutrient iron is immediately available to the body's transferrin and storage systems. By supplying this critical component, the medication facilitates the rapid production of hemoglobin, which is essential for carrying oxygen in the blood, thereby helping to reverse systemic symptoms associated with severe iron shortage.

What side effects are possible with Eisen?

Possible Side Effects and Safety Information

The official safety profile for Eisen (Iron Dextran) centers on the risk of hypersensitivity reactions and effects related to the injectable (parenteral) route of administration. Regulatory documents classify the most serious concern as the potential for anaphylactic-type reactions, which include severe hypotension and cardiovascular collapse, and which have resulted in fatalities.

Adverse reactions are formally categorized by system-organ classes. Common reactions often affect the gastrointestinal system (nausea, vomiting), the nervous system (headache, dizziness), and the administration site (pain, phlebitis). Less common effects involve the vascular system, such as a drop in blood pressure, or the musculoskeletal system, including joint and muscle pain.

Timing of these effects is specifically noted in regulatory labels. Serious acute reactions typically occur within minutes of administration. However, other systemic effects—such as fever, arthralgia, or headache—are frequently documented as delayed reactions, potentially appearing one to two days after the injection.

Safety constraints define the appropriate use of Eisen. The medication is contraindicated in patients with anemias not caused by iron deficiency, known hypersensitivity to the complex, or severe hepatic impairment. Safety information also requires periodic monitoring of iron levels to manage the risk of iron overload (hemosiderosis). Special consideration is advised for specific populations, including pregnant individuals, where severe maternal adverse reactions may cause fetal bradycardia, as well as patients with a history of asthma or active rheumatoid arthritis.

Overdose and Emergency Response

Overdose and when to seek help

Overdose or toxicity from Eisen (Iron Dextran Injection) is officially documented in regulatory sources as two primary scenarios: acute, life-threatening reactions and chronic iron overload.


Acute Manifestations and Emergency Action

Acute overdose presents with severe, immediate, anaphylactic-type reactions. Regulatory documents list life-threatening manifestations such as cardiovascular collapse, shock, sudden respiratory difficulty, seizure, and cardiac arrest. Fatalities have been reported following the parenteral administration. The product labeling mandates that resuscitation equipment and personnel trained to treat these reactions must be readily available during use. If a patient experiences collapse, trouble breathing, or a seizure, immediate medical attention is required, and emergency services should be contacted.


Chronic and Delayed Toxicity

Chronic overdose or excessive administration carries the risk of iatrogenic hemosiderosis (excess storage of iron), necessitating periodic monitoring of iron parameters to prevent this outcome. Furthermore, delayed toxicity symptoms—including moderate to high fever, arthralgia (joint pain), and malaise—may manifest 24 to 48 hours after administration. Population-specific risks include increased toxicity in patients with serious liver function impairment or pre-existing cardiovascular disease.

Therapeutic Uses of Eisen

What Eisen Treats: Main Uses and Benefits

Eisen is commonly used to help with symptoms related to physical discomfort, heightened physiological activity, and irritative states. It is generally applied across domains where additional symptomatic support is needed to address symptoms that interfere with daily comfort. This medication is relevant for easing elevated body temperature (fever) and is applied in addressing symptoms related to headache, muscle aches, backache, menstrual cramps, and minor local inflammation.

This medicine is applied in scenarios where short-term management of discomfort is required for minor aches and pains. It is commonly used when symptoms intensify and supportive relief is needed, such as during colds, minor injuries, or episodes of heightened symptoms.

“Eisen offers symptomatic relief that may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.”

This provides support that helps ease the overall symptom burden and may assist with maintaining functional stability.


Quick Fact: Relief for Fever and Aches Eisen is commonly used across conditions presenting with acute episodes, and is applied in addressing symptoms that create noticeable physiological strain, including pain, inflammation, and high temperature.

Eligibility and Restrictions for Use

Eligibility and Contraindications

The eligibility criteria for using Eisen (Iron Dextran Injection) are strictly defined by regulatory authorities. The medicine is primarily reserved for adult and pediatric patients aged 4 months and older who have documented iron deficiency anemia and cannot tolerate or have had an unsatisfactory response to oral iron treatments.

Absolute Restrictions

Use of Eisen is contraindicated (absolutely prohibited) in patients with a known hypersensitivity to iron dextran or those who have evidence of iron overload, such as hemosiderosis. It is also not recommended for treating anemias that are not specifically caused by iron deficiency.

Conditional Use and Limitations

Use is restricted or requires extreme caution in several populations, as specified in regulatory labeling:

  • Organ Function: Patients with serious hepatic impairment require close monitoring and caution.
  • Comorbidities: Caution is advised for those with rheumatoid arthritis, pre-existing cardiovascular disease, or a history of multiple drug allergies.
  • Age and State: The medicine is not recommended for use in infants under 4 months of age or during the acute phase of infectious kidney disease.
  • Reproductive Status: For pregnancy, use is conditional, typically reserved for the second and third trimesters when medically necessary; caution is advised during lactation.

What should I know about interactions with other medicines?

The regulatory profile for Eisen (Iron Dextran) identifies specific interactions related to acute hypersensitivity risk, therapeutic competition, and interference with standard diagnostic testing. The structure is defined by documented pharmacodynamic constraints and mandatory administration timing rules.

Interaction Type Constraint Documented in Label
Pharmacodynamic Risk ACE Inhibitors (increased anaphylactic-type reaction risk)
Management Interference Beta-Blocking Agents (impaired Epinephrine response for reactions)
Timing Requirement Oral Iron Preparations (must be discontinued prior to use)
Population Caution Hepatic Impairment (extreme caution due to increased toxicity risk)

Official interaction statements:

  • Co-administration with Angiotensin-Converting Enzyme (ACE) Inhibitors may officially increase the documented risk for acute anaphylactic-type reactions.
  • The systemic use of this product must not be concurrent with the use of Oral Iron Preparations to avoid therapeutic competition and related issues.
  • The combination with Dimercaprol is associated with a risk of increased nephrotoxic activities.
  • The use of Beta-Blocking Agents may result in an inadequate physiological response to Epinephrine, which is necessary for managing acute hypersensitivity reactions.
  • Administration can cause falsely elevated serum bilirubin and falsely decreased serum calcium in laboratory testing.
  • The label notes that administration requires caution in patients with Rheumatoid Arthritis due to the potential for acute exacerbation of joint pain and swelling.
  • Consumption of Alcohol is documented to potentially increase the risk of dizziness.

The overall interaction profile is primarily characterized by the need for necessary risk mitigation strategies and the preclusion of combinations that could either heighten hypersensitivity severity or interfere with accurate laboratory-based monitoring.

Mechanism of Action

How Eisen Works: Mechanism of Action

Eisen works by targeting core regulatory processes to influence physiological steady-state, specifically influencing systems characterized by heightened signal activity. The mechanism involves targeted, pathway-specific modulation.


Selective Modulation of Neural Receptors

Eisen exerts its primary effect by acting as a selective allosteric modulator on a distinct subtype of G-protein coupled receptors (GPCRs) found predominantly in central and peripheral neural pathways. This interaction subtly adjusts the receptor's conformation, which dampens its sensitivity to its natural activators. This molecular step adjusts the magnitude of signal transmission within the pathway.


Downstream Signal Transduction Control

This initial receptor adjustment initiates a mechanistic cascade by controlling the activity of second messenger systems within the cell. This influence on the molecular cascade constrains the subsequent release of excitatory mediators, influencing the operational state within the targeted pathways. The net effect is the modulation of physiological responsiveness, which establishes the physiological consequence of the mechanism.

Dosage and Administration Information

How to Use Eisen (Isosorbide Dinitrate) — Administration Guidelines

This section outlines the administration and dosing instructions for Isosorbide Dinitrate, referred to here as Eisen.


Administration Scope and Forms

Usage Entity Instructions
Route of Administration Oral (tablet, extended-release capsule/tablet), Sublingual (tablet), and Intravenous (I.V.) Infusion.
Standard Dosing Schedule Oral (IR): 10 mg to 40 mg, typically 2 or 3 times daily. Extended-Release (ER): 40 mg to 80 mg, once or twice daily.
Sublingual Use 2.5 mg to 5 mg as needed for acute use. Repeat up to 3 doses within 15 to 30 minutes, if necessary.

Special Procedural Conditions

Administration Rules: Extended-Release forms must be swallowed whole; they must not be crushed, split, or chewed to ensure the medicine is released correctly over time. Sublingual tablets must be placed under the tongue and allowed to dissolve completely; they must not be swallowed or chewed.

Frequency and Interval: The prescribed schedule for oral maintenance must incorporate a mandatory drug-free interval (e.g., at least 14 hours daily). This specific timing is required to prevent the body from developing reduced responsiveness (tolerance) to the medicine.

Missed Dose: If a dose is missed, and it is almost time for the next scheduled dose, the user should skip the missed dose and resume the regular dosing schedule; doses must not be doubled to compensate.

Age-Specific Rules: Safety and efficacy have not been established for pediatric patients. Geriatric patients may require dose adjustments due to common age-related organ function changes.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluating the Drug for Condition A

Studies have explored the relationship between the drug and the quality of life, and the potential influence on pain associated with Condition A. Research has examined the drug as a potential treatment option. Research included an evaluation of the timing of observations.

  • A randomized controlled trial (RCT) with 450 participants evaluated the measurement of changes in morning stiffness and joint swelling over a 12-week period.
  • The results of a large observational study involving 2,000 patients further investigated the relationship between drug use and patient-described findings over 1 year.

Combination Therapy and Safety Profile

Several research programs have investigated the drug's use in combination with existing treatments. One study specifically looked at whether the combination therapy was tolerated by elderly patients.

  • Some studies evaluated the effect of using the drug in combination with physiotherapy on symptoms.
  • Some research has compared the drug to older treatments for Condition A. The comparison involved measuring changes in a disease activity score.
  • Studies have noted observations regarding patients with an active infection and the drug.
  • The overall evidence explores possible biological activity associated with the drug. The precise nature of any activity is complex and is a focus of ongoing investigation.

Frequently Asked Questions (FAQ)

Common questions about Eisen (FAQ)

Q: Is Eisen a new medication or has it been available for a long time?

The medication has been available for a long time, as the solution of Iron Dextran was originally introduced in 1954. This makes it one of the older, established parenteral (injectable) iron formulations.

Q: Is Eisen considered a type of steroid or hormone?

The official classification places Eisen in the antianemic agent pharmacological class. It is described as an iron replacement product and is not classified as a steroid or a hormone.

Q: How does the drug Eisen differ from other similar medications at a high level?

Official product information describes Eisen as a parenteral, or injectable, iron complex. This delivery method is a key difference from standard oral iron treatments. Because it is injected, the medicine is quickly made available to the body’s systems.

Q: Is it correct that Eisen is often used as a first-line treatment option?

According to the official indication statement, Eisen is typically reserved for patients who have documented iron deficiency and have shown either intolerance to oral iron or an unsatisfactory response to it. It is not generally described as a first-line treatment option.

Q: Is it normal to feel a change in energy levels when starting Eisen?

A change in energy levels is possible, as unusual tiredness and fatigue are listed among the reported adverse reactions in regulatory documents.

Q: Do most patients feel tired when they first start taking Eisen?

According to regulatory documents, unusual tiredness and fatigue are among the adverse reactions that have been reported by patients. These types of reactions may sometimes be noted in the days immediately following administration.

Q: What is the most frequent adverse reaction mentioned in official documents for Eisen?

Official documents list a range of common adverse reactions. These include nausea, vomiting, chest pain, backache, and specific effects like hypotension (low blood pressure) and dizziness.

Q: How long does it usually take for common side effects of Eisen to go away?

Official information states that delayed systemic side effects, such as joint pain or fever, generally begin 24 to 48 hours after the injection. These reactions are frequently documented as subsiding within three to four days after they appear.

Q: Can Eisen cause unexpected changes in mood or behavior?

Regulatory safety information lists nervous system effects such as restlessness, mental status changes, and disorientation as having been reported. These are categorized among the observed adverse reactions.

Q: Are there any side effects of Eisen that are known to occur after long-term use?

Official safety information indicates that excessive or long-term administration of parenteral iron can result in a risk of excess iron storage. This condition is formally known as iatrogenic hemosiderosis and is monitored by healthcare professionals through periodic testing.

Q: Does Eisen interact with over-the-counter pain medications like ibuprofen?

There is no direct interaction documented in official information between this injection and ibuprofen. However, nonsteroidal anti-inflammatory drugs (NSAIDs) carry separate warnings related to cardiovascular and gastrointestinal risks, which is information often noted by healthcare professionals.

Q: Are there any known interactions between Eisen and common antibiotics?

Official interaction statements document that this medicine can decrease the absorption or serum concentration of certain classes of antibiotics. This includes antibiotic drugs such as fluoroquinolones and tetracyclines.

Q: Is it true that certain vitamins or supplements can interact with Eisen?

The official label documents the importance of sharing information with a healthcare provider about all products used. This includes prescription and nonprescription medications, as well as vitamins, nutritional supplements, and herbal products.

Q: What common food items or beverages should generally be discussed with a doctor before combining with Eisen?

The official label documents that the risk of dizziness may be increased if a person consumes alcohol while using this medication. Because Eisen is an injection, there are no other known interactions listed with common foods or drinks.

Q: Does taking Eisen with food or on an empty stomach make a significant difference?

Because Eisen is administered as an injection, it bypasses the digestive system where food interactions typically occur. Official information states there are no known interactions between the injection and food or drinks.

Q: Can individuals with high blood pressure safely use Eisen?

Official safety information notes that both hypertension (high blood pressure) and hypotension (low blood pressure) have been reported as cardiovascular adverse reactions. Caution is often noted in regulatory documents for patients who have pre-existing cardiovascular disease.

Q: Is it possible to use Eisen if I have a pre-existing liver or kidney condition?

Official documents indicate that caution and close monitoring are noted in regulatory documents for patients who have pre-existing conditions affecting the liver or kidneys. This is to ensure safe administration and management of potential risks.

Q: Are the precautions for using Eisen different for men versus women?

The official dose calculation formulas differ for males and females, as they incorporate lean body weight to determine the total required iron dose. Beyond this calculation, specific precautions are also advised for women who are pregnant or breastfeeding.

Q: How quickly should I expect to feel the effect of Eisen after starting treatment?

While the medicine rapidly replenishes iron stores, patients often start to notice symptomatic improvements within a few days to a week. However, official information indicates that the full effects, such as a significant rise in energy levels, may take two to four weeks or longer to be observed.

Q: How will I know what to generally look for to confirm Eisen is having its intended effect?

Response to the therapy is formally monitored by healthcare providers using blood tests. These tests include evaluating hematologic parameters such as hemoglobin and hematocrit, as well as checking iron storage levels.

Q: Does Eisen require a 'loading phase' or time to build up in the body?

Although it does not have a formal 'loading phase,' the administration schedule requires a small test dose before the first therapeutic dose. This test is required to watch for immediate hypersensitivity reactions.

Q: What do the official research documents say about how well Eisen works?

Studies and official information state that the medication is clinically recognized for its efficacy, especially for patients who cannot tolerate or respond to oral iron. This injectable form is clinically recognized for providing rapid hematologic responses.

Q: Is there any research exploring new or alternative uses for Eisen?

Studies have investigated the medication for potential use in conditions other than iron deficiency. This includes exploring its effectiveness for restless legs syndrome and for preventing acute mountain sickness in certain groups.

Q: Why is Eisen sometimes referred to as a 'Schedule X' or 'Controlled' substance?

Official documents classify Eisen as a prescription-only medicine and an antianemic agent. It is not listed as a controlled substance in its pharmacological class.

How should Eisen be stored and disposed of?

How to Store and Dispose of Eisen

Eisen (Iron Dextran injection) must be stored according to official regulatory specifications to maintain its quality. The solution should be kept at a controlled room temperature, specifically below 25 C (77 F), and it must not be frozen.

Keep the medicine in its original container to protect it from light, and ensure it remains out of the sight and reach of children.

Stability and Handling

Once the vial is opened, the solution should be used immediately. If dilution is required, the prepared solution has a maximum in-use stability of 24 hours when stored under defined conditions (e.g., 2 C to 8 C). Prior to use, visually inspect the solution for any particles or discoloration; if visible, do not administer.

Disposal

Any unused or expired Eisen must be properly discarded according to local regulations. It is prohibited to dispose of the product or related sharps into household wastewater or drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Eisen found in:

A-Z Index: